RCE in Ibm Aix
CVE-2023-28528
IBM AIX 7.1, 7.2, 7.3, and VIOS 3.1 could allow a non-privileged local user to exploit a vulnerability in the invscout command to execute arbitrary commands. IBM X-Force ID: 251207.
Vulnerability class: Command Injection (OS Command Injection)
EPSS: 0.015 (70.6th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 8.4 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
Affected products
Weakness classification (CWE)
Public proof-of-concept exploits
References
- psirt@us.ibm.com (vendor-advisory, Patch, Vendor Advisory)
- psirt@us.ibm.com (VDB Entry, vdb-entry, Vendor Advisory)
- psirt@us.ibm.com
- af854a3a-2127-422b-91ae-364da2661108
Frequently asked questions
- What is CVE-2023-28528?
- CVE-2023-28528 is a high-severity vulnerability in Ibm Aix, classified under OS Command Injection. CVSS score: 8.4/10. Published 2023-04-28.
- How severe is CVE-2023-28528?
- High severity. CVSS v3 base score is 8.4 out of 10.
- Is CVE-2023-28528 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.